'Authorising biomedicines expensive, stiff and time-consuming'

Due to various European regulations, the authorization of new biological crop protection products is unnecessarily expensive, stiff and time-consuming. This is apparent from new research by, among others, Wageningen University & Research (WUR).

The researchers argue that fewer sustainable products (based on micro-organisms) are coming onto the market as a result. This is at odds with the rapid, green transition of the agricultural sector that the European Union and the Dutch government have in mind. For example, the European Citizens' Initiative already advocated this week complete elimination of synthetic crop protection products in 2035.

Too strict
A conclusion that research is that the requirements for admission are often too strict. The authorization of 1 biological agent can take up to 5 years. According to Jürgen Köhl, a researcher at WUR, biological agents should be assessed in a different way than chemical agents. "In order to actually take steps towards sustainable agriculture, the authorization of biological resources must become faster and cheaper."

Jeanette Pennings

Jeannet has her roots in the flower bulb sector and she grew up on an agricultural company in the northern part of North Holland. As a generalist she reports for Boerenbusiness across all sectors. She is also exploring the possibilities of sponsored advertising.

j.pennings@boerenbusiness. Nl

© DCA Market Intelligence. This market information is subject to copyright. It is not permitted to reproduce, distribute, disseminate or make the content available to third parties for compensation, in any form, without the express written permission of DCA Market Intelligence.